Navigation Links
Lose Weight To Reduce Risk Of Diabetes – Says A New Researc

Saint Louis, researcher and member of Washington University team of scientists induces a query: Which works best in fighting the risk factors // for diabetes – exercise or diet?

It's a toss up – answers Louis, who is currently involved in new research, a part of longevity study funded by NIH, examining whether a calorie-restrictive diet can extend lifespan of people who are under the mercy of diabetes.

"Both diet and exercise provide profound benefits to reduce the risk of diabetes. Both those who restrict calories and those who exercise benefit from weight loss," says Edward Weiss, Ph.D., lead author and assistant professor of nutrition and dietetics at Saint Louis University's Doisy College of Health Sciences.

"We thought exercise probably would produce greater benefits. But both of these are providing beneficial health improvements."

Weiss said the scientists looked at markers for developing diabetes because the disease is one of the main causes of premature death.

The researchers studied 50 to 60 year olds whose body mass index was between 23 and 30. That places them at the high end of normal weight or overweight, but not obese.

"People weren't way out of whack in terms of their body composition," Weiss says.

The study participants were divided into three groups –- with 18 each in the diet and exercise groups and 10 in the control group. The yearlong study was funded by the National Institutes of Health.

All participants had their insulin action and glucose tolerance, which both are markers for diabetes, evaluated at the beginning and end of the study. In addition, their weight, body composition and energy intake were measured at the beginning of the study and at one, three, six, nine and 12-month intervals.

Those who restricted calories met weekly with a dietitian who helped them develop individualized menu plans and guided them to reduce portion sizes and replace high ca
'"/>




Page: 1 2

Related medicine news :

1. Lose Weight With New Wonder Slimming FDA approved Prescription Drug
2. Weight-Loss Drinks Can Make You Gassy
3. Smoking Linked To Low Infant Birth Weight
4. Weight gain following smoking cessation not linked to Leptin
5. Helping Kids Attain a Healthy Weight
6. Weight-loss Products Dangerous
7. Weight and Blood Pressure
8. Low Birth Weight infants could have Problems in the Future
9. Excess Weight Can Affect Individuals as They Age
10. Low-Fat, High-Carb Diet Equally Effective In Weight Loss
11. Weight Gain Found To Increase The Risk Breast Cancer
Post Your Comments:
(Date:12/16/2009)... site visitors can earn a free 21-count one week trial bottle ... ... Orion, MI (PRWEB) December 16, 2009 -- ImmuneResponse247.com ... Trial Sample” of Immune Response 247™ 6 Mushroom Formula , ... Medicinals, Immune Response 247™ 6 Mushroom Formula is packaged in FDA ...
(Date:12/16/2009)... Request A Test, Ltd. is proud to announce being presented with ... Weatherhead 100 showcases the fastest growing companies in Northeast Ohio and ... to succeed. , ... (PRWEB) December ... being presented with the Weatherhead 100 Upstart Award on December 3, ...
(Date:12/16/2009)... approaching and what would be the perfect gift to give that ... Celebrity Beauty Engineer® and Licensed Esthetician Mary Schook introduces exceptional beauty ... feel their best! , ... (PRWEB) December 16, 2009 ... does a person get that special woman who has everything? Why ...
(Date:12/15/2009)... SUMMARY: The U.S. Senate today rejected an ... Act that would have helped make prescription drugs ... legal importation of lower priced drugs from abroad. ... by Senators Dorgan, Snowe, McCain, Grassley and Stabenow, ... down the skyrocketing costs of prescription drugs. ,, ...
(Date:12/15/2009)... coal for lying about taxes in the healthcare bill ... has earned a place under the "Naughty" column on Americans ... after being caught telling a brazen lie on the floor ... bill would not raise taxes. ,, Speaking on the ... " I have also heard it ...
Breaking Medicine News(10 mins):Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 2Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 3Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 4Health News:Request A Test Receives Weatherhead 100 Upstart Award 2Health News:New Online Beauty Store Suggests Stem Cells for the Woman Who Has Everything 2Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 2Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 3Health News:ATR: Baucus Earns Place on 2009 "Naughty" List 2Health News:ATR: Baucus Earns Place on 2009 "Naughty" List 3
... and the University of Pennsylvania have been able to ... Celebrex and Vioxx, administered for treatment// of pain and ... heart problem ,Co-author Colin Funk, a professor of ... in Molecular, Cellular and Physiological Medicine has expressed optimism ...
... Ear Hospital in East Melbourne, Australia says that simple corneal ... so might actually slow healing and does not reduce pain, ... ,“The abrasions on the eye normally don’t affect vision too ... if there is no good reason to do so,” Turner ...
... elderly people turn to God as they approach death. This ... their earlier days.// The study, which appears in the March ... may actually increase the fear of dying in such people. ... hospice patients in North Central Florida all of who were ...
... According to a Pakistani local newspaper three persons with a ... Institute of Medical Sciences (PIMS). //The patients are currently under ... virus. ,According to The News, 22-year-old Syed Wali, his ... brought to the PIMS following manifestation of symptoms of bird ...
... new study by Northeastern University professor Debra L. Franko white ... continue feeling the same.// ,More than two thousand ... the conclusion by the researchers was that the depression rate ... in their African-American counterparts. The study was published in a ...
... your child is getting too little calcium, think twice as ... and calcium-fortified foods that builds stronger bones.// ,"The review ... has little benefit for bone health," said lead author Tania ... as a public health policy for healthy children, the review ...
Other Medicine News:Health News:Calcium Supplements May Not Be Of Much Use For Healthy Kids 2
(Date:12/16/2009)... Naurex Inc., a new clinical stage company developing ... based on its novel GFPA NMDA receptor modulators, ... I clinical trial of its lead compound GLYX-13 ... the study. GLYX-13, a glycine site functional ... receptor, is initially being developed as a therapy ...
(Date:12/16/2009)... Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) ... 3 registration clinical trial for KRX-0401 (perifosine), ... / refractory multiple myeloma patients. ,, The ... to Assess the Efficacy and Safety of ... (Velcade®) and Dexamethasone in Multiple Myeloma Patients ...
(Date:12/15/2009)... Ireland, Dec. 15 Warner Chilcott plc ... subsidiary Warner Chilcott Corporation (the "Company") has commenced ... subject to the conditions set forth in the ... dated December 15, 2009 (the "Offer to Purchase"), ... senior subordinated notes due 2015 (the "Notes"). ,, ...
Breaking Medicine Technology:Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 2Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 3Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 2Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 3Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 4Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 5Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 6Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 7Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 2Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 3Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 4Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 5Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 6Scientists closer to making implantable bone material thanks to new research 9358 1Scientists closer to making implantable bone material thanks to new research 9358 2Assara Laser Hair Removal Centers 28New York NY 29 Receives 2008 New York Award for Cosmetology 26amp 3B Personal Hygiene Salons by the U S C A 52713 1Assara Laser Hair Removal Centers 28New York NY 29 Receives 2008 New York Award for Cosmetology 26amp 3B Personal Hygiene Salons by the U S C A 52713 2SpeechEasy Seeks Proposals For Future Research Studies 52708 1SpeechEasy Seeks Proposals For Future Research Studies 52708 2SpeechEasy Seeks Proposals For Future Research Studies 52708 3
... CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 25, 2007 - Elixir,Pharmaceuticals, ... sets,of preclinical data demonstrating that ghrelin antagonism ... of a range of metabolic,disorders. These data ... decreasing body weight, improvements in,blood glucose and ...
... highly potent DPP-4 inhibitor, possessing Ki of 27,pM, ... a privately held drug discovery biopharmaceutical company,announced today ... presented at the 67th session of the American ... that,ARI-2243 is an extremely long acting, potent inhibitor ...
Other Medicine Technology:Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its,Ghrelin Antagonist Program at the American Diabetes Association's,Annual Meeting 2Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its,Ghrelin Antagonist Program at the American Diabetes Association's,Annual Meeting 3Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its,Ghrelin Antagonist Program at the American Diabetes Association's,Annual Meeting 4Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4,Inhibitor, ARI-2243, at the ADA 2Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4,Inhibitor, ARI-2243, at the ADA 3Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4,Inhibitor, ARI-2243, at the ADA 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: